Clinical symptoms of COVID-19 pneumonia in children

Tang, Zhengwu; Li, Muzhe; Chen, Wei; Ran, Xun; Li, Huiyun; Chen, Zhiwei

doi:10.1097/md.0000000000024108

Cited by 3 publications

(2 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The main symptoms of COVID-19, such as cough, fever, and dyspnea are important in the early diagnosis of COVID-19 disease (Alimohamadi et al, 2020). Identifying the clinical symptoms of COVID-19 in children is crucial in terms of accurately predicting the course of the disease (Tang et al, 2021). Many scientific studies have been conducted to specify the role of these symptoms in the diagnosis of COVID-19.…”

Section: Introductionmentioning

confidence: 99%

Analysis of Symptoms and Demographic Characteristics in Diagnosis of COVID-19 by Logistic Regression Model

Tanış

2024

Selçuk Üniversitesi Fen Fakültesi Fen Dergisi

View full text Add to dashboard Cite

The new coronavirus COVID-19 is an infectious disease that started spreading globally in December 2019. Some symptoms are known to give clues as to whether the COVID-19 virus is infected. Therefore, the main purpose of this paper was to determine specific symptoms related to COVID-19 for the rapid diagnosis of COVID-19 cases. The data set consists of 25985 individuals including PCR results, 2 demographic properties (age, gender), and 5 symptoms such as headache, shortness of breath, sore throat, fever, and cough is considered in this study. We analyzed the relationship between these covariates and PCR results by binary logistic regression model. A total of 16405 (63.1%) individuals having to positive PCR results were included in this study. The research population was divided into two age groups (

show abstract

Section: Introductionmentioning

confidence: 99%

Analysis of Symptoms and Demographic Characteristics in Diagnosis of COVID-19 by Logistic Regression Model

Tanış

2024

Selçuk Üniversitesi Fen Fakültesi Fen Dergisi

View full text Add to dashboard Cite

show abstract

“…Regarding the evolution of the clinical view of a patient infected with SARS-CoV-2, in general, patients present an incubation time of 5.2 d [8] and some of the main systemic and complications are: fever, cough, hypoxemia, groundglass opacity, sore throat, pneumonia, among others symptoms [9][10][11] that can be present between 6 and 41 d. It is noteworthy that infections present in the respiratory tract such as pneumonia, caused by SARS-CoV-2 and/or associated with a pathogenic microorganism (fungi and/or bacteria) i.e. S. pneumoniae, represents a high mortality rate among patients infected with SARS-CoV-2 [12,13].…”

Section: Introductionmentioning

confidence: 99%

Perspectives on photobiomodulation and combined light-based therapies for rehabilitation of patients after COVID-19 recovery

Dias¹,

Blanco²,

Faria³

et al. 2022

Laser Phys. Lett.

View full text Add to dashboard Cite

The post-COVID-19 condition or ‘long COVID’ is a clinical and scientific challenge for society. In this regard, patients after COVID-19 recovery show a vast range of sequels including muscular, articular lesions, neurological, dermatological, and pulmonary issues. These clinical consequences are issues in the present and for the future. In this case, rehabilitation therapies based on photobiomodulation and combined therapies arise as excellent tools to solve it. Herein, we describe and discuss the perspectives on the use of light-based therapies such as photobiomodulation, photodynamic therapy and combined vacuum and laser therapy for rehabilitation of patients who present some sequelae of the COVID-19 infection. We did not intend to produce a comprehensive review; instead we highlight the most important and clinical protocols against these sequels. Moreover, the principles and mechanism of action of each light-based technique proposed were reported and discussed.

show abstract

Severe acute respiratory syndrome coronavirus 2 infection rate among pediatric patients with respiratory symptoms

Samerton,

Apiwattanakul,

Assawawiroonhakarn

et al. 2024

Pediatrics International

View full text Add to dashboard Cite

BackgroundThe incidence of coronavirus disease 2019 (COVID‐19) in children has been increasing worldwide since the onset of the pandemic. This study examined the risk factors and characteristics of COVID‐19 among pediatric patients compared to other respiratory viral infections.MethodsThis was a prospective cross‐sectional study. Patients aged 0–18 years presenting with respiratory symptoms from October 2020 to December 2021 were included. Demographic and clinical data were reviewed.ResultsIn total, 738 pediatric patients were enrolled. Of these, 48.5% had COVID‐19, and 41.3% were infected with another respiratory virus. The COVID‐19 incidence increased from 0.5% during the original strain outbreak (October 2020 to March 2021) to 56.5% and 73.4% during the alpha (April to June 2021) and delta (July to December 2021) periods, respectively. Children aged 6‐18 years, being female, obesity, exposure to household members with COVID‐19, and the delta period were risk factors for COVID‐19. Being aged 1‐5 years, obesity, shortness of breath, productive cough, and chest pain were associated with COVID‐19 pneumonia. Children aged 5–18 years, underlying neurological disease, a history of COVID‐19 pneumonia, and the delta period were associated with long COVID.ConclusionsPediatric COVID‐19 patients presenting with respiratory symptoms who are obese or have been exposed to household members with COVID‐19 should be tested for COVID‐19. COVID‐19 patients who are obese, younger than five years old, or who present with shortness of breath, productive cough, or chest pain should be evaluated for pneumonia. COVID‐19 patients with a history of COVID‐19 pneumonia or underlying neurological disease should receive follow‐up for long COVID.

show abstract

Clinical symptoms of COVID-19 pneumonia in children

Cited by 3 publications

References 11 publications

Analysis of Symptoms and Demographic Characteristics in Diagnosis of COVID-19 by Logistic Regression Model

Analysis of Symptoms and Demographic Characteristics in Diagnosis of COVID-19 by Logistic Regression Model

Perspectives on photobiomodulation and combined light-based therapies for rehabilitation of patients after COVID-19 recovery

Severe acute respiratory syndrome coronavirus 2 infection rate among pediatric patients with respiratory symptoms

Contact Info

Product

Resources

About